TECTONIC THERAPEUTIC, INC. Increase (Decrease) in Other Noncurrent Liabilities
TECTONIC THERAPEUTIC, INC. (TECX) reported Increase (Decrease) in Other Noncurrent Liabilities of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2025-03-20
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2023-12-31 was $0.00.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2017-12-31 was $0.00.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other noncurrent liabilities for fiscal 2023 was -$56.00K.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in other noncurrent liabilities for fiscal 2017 was $500.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$56.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | -$56.00K 10-Q · filed 2024-11-12 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $500.00K 10-K · filed 2019-03-25 | |
| 2017-09-30 | $500.00K 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |